Skip to main content
Journal of Atrial Fibrillation logoLink to Journal of Atrial Fibrillation
. 2012 Feb 2;4(5):465. doi: 10.4022/jafib.465

Left Atrial Diastolic Dysfunction following Catheter Ablation of Atrial Fibrillation

Hsin Yueh Liang 1, Ruey J Sung 2,*
PMCID: PMC5153005  PMID: 28496716

Abstract

Radiofrequency catheter ablation (RFCA)-induced thermal injury may cause and/or worsen left atrial (LA) diastolic dysfunction leading to pulmonary hypertension and heart failure in patients with atrial fibrillation (AF), the incidence of which is probably more common than is generally realized. Biplane 2-dimensional echocardiography coupled with tissue Doppler (velocity) imaging and Doppler-derived strain (rate) imaging can be applied to provide quantitative assessment of the LA function (both systolic and diastolic) relative to pulmonary venous circulation and left ventricular function. Information so obtained is useful for guiding follow-up management of patients undergoing RFCA of AF.

Introduction

Radiofrequency catheter ablation (RFCA) has evolved to become an important treatment modality for drug refractory symptomatic paroxysmal and persistent atrial fibrillation (AF).[1] The success rate RFCA of AF is estimated to be 60-80 % in a worldwide survey.[1] Although short-term follow-up studies have shown that RFCA significantly improves the quality of life in patients suffering from such an arrhythmia, its long term effects on the incidence of stroke and heart failure and the overall mortality remain to be determined.[1,2]Recently, Gibson et al.[3] used right heart catheterization to investigate 19 patients (out of 1380 consecutive patients) who had developed unexplained dyspnea with “less than mild” mitral regurgitation on echocardiography after RFCA of AF. They demonstrated “new or worsening” pulmonary hypertension alongside diastolic dysfunction of the left atrium (LA) reflected as large V waves recorded on pulmonary capillary wedge or LA pressure tracings in the absence of significant mitral regurgitation in these patients. These findings were indicative of LA diastolic dysfunction, consistent with the so-called “stiff LA syndrome” originally observed in patients, status post-surgical replacement of the mitral valve.[4] Despite the incidence being relatively small (1.4%), they implied that RFCA-induced scarring of the LA was the culprit and the “stiff LA syndrome” could have accounted for pulmonary hypertension and symptoms of heart failure in these patients. Since the LA diastolic function is seldom contained in the evaluation of patients following RFCA of AF, we aim to review the subject and propose the use of two-dimensional (2-D) echocardiography along with tissue Doppler imaging and Doppler-derived strain (rate) imaging for noninvasive quantitative assessment of the LA function [5,6]in managing this subset of patients.

Effects of Radiofrequency Catheter Ablation on Systolic Function of Left Atrium

RFCA of AF is considered a relatively invasive and complex procedure. It requires trans-septal placement of mapping and ablation catheters from the right atrium to the LA and application of radiofrequency energy to produce thermal injury to the LA tissue.[1,6] An extensive area of RFCA seems required for successful elimination of AF.[8] However, because of the complexity of the trigger/substrate of AF, the exact extent of the area and the amount of tissue needed to be ablated in the LA remain debatable. Consequently, the procedure strategy varies greatly among different centers.[01,07] In general, for effective restoration of sinus rhythm, a “stepwise approach” is preferred, i.e., circumferential pulmonary vein (PV) isolation followed by ablation lines created in the roof, anterior wall, septum, mitral isthmus, and/or posterior annulus, and if deemed necessary, additional ablation of fractionated atrial electrograms is performed.[1] As such, it is hoped that sufficient scar tissue can be created in the LA to prevent initiation of any sustainable reentrant arrhythmias.

It has been shown that RFCA can produce scarring and fibrosis of the atrial wall with subsequent thinning.[9] To assess the effect of scar tissue so created on the LA function, Wylie et al.[10] performed cardiovascular magnetic resonance imaging (MRI) in 33 consecutive patients with paroxysmal or persistent AF before and after (mean 48 days) circumferential PV isolation. They noted that the maximum LA volume decreased by 15% (P <0.001), whereas LA ejection fraction decreased by 14% (P<0.001) in 16 patients of the study cohort in whom high spatial resolution late gadolinium enhancement MRI images of LA scar were obtained. Of note, the decrement in LA systolic function correlated well with the amount of LA scar presumably produced by RFCA (mean LA scar volume 8.1 ± 3.7 ml; r = -0.75, P <0.001). They concluded that that LA scar produced by RFCA could adversely affect the LA systolic function and thus raised concern that procedures with extensive RFCA might increase the risk of post-procedural thromboembolism. No LA diastolic function relative to the amount of LA scar was evaluated in the study.

Numerous clinical studies have attempted to address the effects of the RFCA procedure on the LA. Jeevanantham et al.[11] identified 17 out of 192 studies, enrolling 869 patients, in which primary outcomes had been set forth for changes in the LA size or volume and/or function before and after RFCA; fixed- and random-effects meta-analyses were used to weigh mean differences for changes in LA diameter, LA maximum volume, LA minimum volume, LA ejection fraction, and LA active emptying fraction. They found that decreases in LA diameter and LA volumes were significant in those without but not in those with AF recurrence and that while LA ejection fraction and LA active emptying fraction decreased in patients with AF recurrence, they did not decrease in patients without AF recurrence. They surmised that successful RFCA in patients with AF significantly decreased the LA size and volume but did not seem to adversely affect the LA systolic function. As had been pointed out by Gibson et al.[3] most of these studies included in this meta-analysis used variable RFCA strategies and were mostly retrospective in nature using consecutive and relatively small sampling designs, and none of them had systemically addressed the issue of RFCA effects on the diastolic function of LA.

Mechanical Function of the Left Atrium in the Presence of Normal and Abnormal Left Ventricular Function

Bridging between the PV system and the left ventricle (LV), normally the mechanical function of LA consists of three phases during the cardiac cycle, serving as a pump, a reservoir, and a conduit, and thereby modulating intermittent filling of the LV.[12] First, the LA contracts right before the onset of the systolic phase of LV establishing the LV end-diastolic volume. Second, it becomes a reservoir that stores PV return during LV contraction and isovolumic relaxation after the closure and before the opening of the mitral valve. Third, the LA provides a conduit that directs its contents into the LV via an LA-LV pressure gradient after the mitral valve opens while continuing to passively transfer PV blood flow during LV diastasis.[11] The relative contribution of the LA pump function to the filling of the LV is estimated to be 25%, whereas those of the reservoir, and conduit functions, are 40% and 35%, respectively.[13] Nevertheless, these 3 phasic functions of the LA can be affected by changes in LV function and age.[14,15] The booster pump contribution to the cardiac output becomes increasingly important to the preservation of cardiovascular performance in patients with LV dysfunction. In the presence of LV diastolic dysfunction (i.e., abnormal relaxation), the relative contribution of LA pump and reservoir functions increase and that of conduit function decreases because of attendant reduction of the LA-LV pressure gradient during early diastole. As LV filling pressure progressively increases due to further deterioration of LV diastolic dysfunction, pump and reservoir functions of the LA can be severely impaired, leaving the LA to serve predominantly as a conduit.[13] Hence, LA function is in a close interdependence with LV function and as a result, LA remodeling is related to LV remodeling.[15] Clinically, when the enhanced significance of LA systole to LV filling is compromised because of severe LV dysfunction or due to AF (loss of atrial pump contribution), patients could then develop signs and symptoms of heart failure. In the latter situation caused by AF, these adverse effects can be reversed or lessened with subsequent restoration of normal sinus rhythm and LA contraction.[13] On the other hand, aging causes structural changes of the LA wall that increase fatty tissue, collagen and fi brosis, leading to progressive remodeling; functionally, the LA reservoir function remains relatively unchanged, whereas its conduit function decreases, which can be an expression of LV diastolic dysfunction.[15]

Imaging Techniques for Evaluation of LA function

There are several imaging methods that can be used for assessing LA anatomy and function.[5] Both multi-slice computed tomography (MSCT) and cardiovascular MRI generate accurate LA and PV anatomy thereby providing useful information prior to RFCA. However, the former contains radiation exposure and the use of contrast agents, and the latter requires relatively long acquisition time and arduous data analysis. More significantly, the cost and the lack of bedside availability preclude them to be the first-line use in the evaluation of LA function.[5] Even in the follow-up care of patients, these two imaging methods are employed only in selected patients. While clinically it is also impractical to routinely perform right heart catheterization, the change of the LA function in different phases can be non-invasively assessed by 2-D echocardiography along with tissue Doppler imaging and Doppler-derived strain (rate) imaging.[5,6]The major shortcoming of the latter techniques is that they are computationally intensive; analysis and interpretation of velocity, strain and strain rate need to be done by well trained specialists.

Two-Dimensional Echocardiography and the Doppler Method for Assessment of LA function

Another area of consideration when referring to LA volumes is that these volumes are usually calculated from apical four- and two-chamber views of the LA using the biplane technique.[5] The LA volume calculated by 2-D echocardiography provides a more accurate measure of the LA size than that of the conventional M-mode echocardiography.[5] Moreover, various LA volumes can be used to describe LA phasic function.[16] Specifically, total LA emptying volume (i.e., an estimate of reservoir volume) can be calculated as the difference between maximum LA and minimum LA volumes; LA passive emptying volume as the difference between maximal LA volume and the LA volume preceding atrial contraction; LA active emptying (contractile) volume as the difference between pre-atrial contraction LA volume and minimum LA volume; LA (passive) conduit volume as the difference between LV stroke volume and the total LA emptying volume and lastly, the LA ejection fraction as the difference between the maximum LA volume and the minimum LA volume divided by the maximum LA volume.

Tissue Doppler imaging quantifies regional tissue motion velocity, whereas Doppler-derived strain and strain rate depict local tissue deformation and measure the rate of deformation, respectively.[5,6,17,18] These two technologies have been validated for the assessment of both global and regional LV function and have recently been extended to the evaluation of regional LA function.[5,6,17,18] Using standard pulsed-wave tissue Doppler imaging, mitral inflow velocities are recorded at the tips of the mitral valve leaflets in an apical four-chamber view.[5,6] The pulsed Doppler profile of trans-mitral inflow is composed of an early (E wave) and late (A wave) diastolic flows. The E wave represents LV filling in early diastole, which is a combination of passive and active LV function when LA acts as a conduit. The trans-mitral A wave reflects LA contractile function. PV flow velocities are measured from the apical four-chamber view usually by sampling the right upper PV. Spectral pulsed Doppler of PV can be used to evaluate LA function as well.[19,20] The first positive wave (PVs wave) during LV systole indicates the reservoir function of LA, and the 2nd positive wave (PVd wave) after the opening of mitral valve acts as LA conduit function. The reversal wave (PVa wave) after P wave on electrocardiogram represents LA contraction which is usually combined with trans-mitral A wave to describe the booster pump function of the LA. Although the Doppler technique is an easy and reproducible way to evaluate LA function, it has been shown to be dependent on the LA loading condition, LA contractile state, and LV function.[20] Therefore, these potential limitations should be taken into consideration while attempting to interpret the LA function using these indices.

To obtain LA Doppler-derived strain (rate) data, a small sample volume of interest, usually less than 12 mm in length, is placed on each mid-segment of the LA wall in four- and two-chamber views.[5,6,17,18] With the use of the trans-mitral Doppler profile of the aortic and mitral valves, different cardiac phases of systole and of early and late diastole can be accurately identified. Peak strain and strain rate are calculated at each of several mid-LA segments (e.g., septal, lateral, anterior, inferior). The LA appendage is a highly contractile structure which provides important reservoir function of the LA, especially when the LA pressure or volume is significantly increased.[21] Due to its anatomical location, the trans-esophageal approach confers better assessment of its structure and function (e.g., the size, emptying and filling velocities).[5,6,[17,18] Analysis of velocity and strain (rate) of the desired atrial segment includes measurements during ventricular systole (Sa), early ventricular diastole (Ea) and late ventricular diastole (Aa). The Aa-wave is regarded as a direct measure of regional active atrial contraction and the Sa and Ea waves represent the passive expansion and emptying components of the LA function. Strain reflecting regional myocardial lengthening is usually expressed as a positive value and strain reflecting regional myocardial shortening a negative value (Figure 1).[5,6,[17,18]

Figure 1. Representative atrial myocardial velocity (upper panel), strain (middle panel) and strain rate (lower panel) tracings are obtained from the left atrial septum. Four-chamber echocardiograms are displayed at the left and ECG at the bottom of each panel. A time interval (red line) depicting R-R of the ECG is shown in the lower panel. AC= atrial contraction; PAF= passive atrial fi lling; S= strain and VS= ventricular systole.

Figure 1.

Relevant Clinical Studies Using the Doppler Method for LA Function Evaluation

Several studies have demonstrated the value of regional atrial strain (rate) in the analysis of patients undergoing external cardioversion. In 65 patients with lone AF for at least 3 months, Salvo et al.[23] demonstrated that these AF patients had significantly reduced atrial myocardial properties compared with healthy controls (velocity, 3.2±1.4 vs. 5.7±1.3 cm/s; strain, 23.3±19 vs. 92±26%; strain rate, 2±0.9-1 vs. 4.2±1.8 seconds-1; P< 0.0001). Using multivariable analysis, they also showed that patients with higher LA strain and strain rate (especially, inferior wall peak systolic strain rate and septal peak systolic strain) had a greater likelihood of maintaining sinus rhythm after external cardioversion. Similarly, in 52 patients with AF for less than 1 year, Wang et al.24 found that compared with healthy controls, the LA velocity measured during ventricular systole (2.36±1.04 vs. 3.68±0.99 cm/s, P< 0.001) and early diastole (2.78±1.26 vs. 3.50±1.11 cm/s, P< 0.05), and the strain rate calculated during ventricular systole (2.05±0.96 vs. 2.83±0.73 seconds-1, P<0.01) were markedly reduced in AF patients. Moreover, the strain rate calculated during ventricular early diastole was significantly lower in patients who failed to respond or had AF recurrence when compared with those without AF recurrence within 4 weeks after external cardioversion (2.32±0.95 vs. 3.17±0.93 seconds-1, P< 0.01). Additionally, they noted that a lower early diastolic strain and larger transverse LA diameter were independent predictors of failure of external cardioversion (HR, 95% CI: 0.36, 0.14-0.88 and 2.85, 1.33-6.10, respectively).

In patients with chronic AF (>3 months and <1 year), Thomas et al.[25] showed that atrial strain was significantly decreased immediately after external cardioversion compared to healthy controls and despite that there was gradual recovery with maximal changes observed in the initial 4 weeks, atrial pump function failed to normalize over time. These latter findings confirmed that atrial stunning,[26] characterized by reduced atrial mechanical function after restoration of sinus rhythm from AF could occur, thereby increasing the risk of thrombo-embolism. Kaya et al.[27] also studied patients with chronic AF and noted that LA (transthoracic approach) and LA appendage (transesophgeal approach) strain and strain rates were significantly lower one day after cardioversion (5.0±2.8%/2.3±1.0; 7.6±3.6%/1.6±0.7, respectively), which subsequently improved 10 days post-cardioversion. These sequential changes in the LA strain and strain rate were in parallel to those changes in the emptying and filling velocities of the LA appendage (e.g., LA systolic strain and LA appendage emptying velocity, r = 0.73, P= 0.007). Thus, these investigators had clearly demonstrated that there was a significant decrease in LA compliance in patients with AF, affecting the reservoir and conduit functions as well as that of the booster pump which is virtually lost during AF. They further advocated that regional LA function as assessed by combined tissue Doppler (velocity) imaging and Doppler-derived strain (rate) imaging could provide insightful information for predicting success or failure for external cardioversion and for guiding anticoagulation and anti-arrhythmic therapy in these AF patients.More relevant to the present subject, Schneider et al.[17] applied Doppler-derived strain (rate) to evaluate 118 patients (74 paroxysmal AF, 44 persistent AF) before and after RFCA for AF. With peak strain rate (SR) and strain (S) measured during systole (LAs) and at early (LAe) and late diastole (LAa), they noted that while both groups of patients had decreased atrial myocardial properties compared with controls after RFCA (Controls:SR-LAs 4.1 seconds-1, S-LAs 88%, SR-LAa 22.9 seconds-1), the extent of decrement was more severe in those with persistent AF (SR-LAs 2.3 seconds-1, S-LAs 25%, SR-LAa 21.9 seconds-1) than those with paroxysmal AF (SR-LAs 2.5 seconds-1, S-LAs 30%, SR-LAa 22.2 seconds-1) (P< 0.011). Moreover, these parameters increased in patients who had maintained sinus rhythm in contrast to patients who had had AF recurrence during a 3-month follow-up (P< 0.001) and the best predictors for maintaining sinus rhythm were cut-off values of 2.25 seconds-1 for septal and inferior SR-LAs and of 19.5% for inferior S-LAs (P< 0.001). They concluded that Doppler-derived strain (rate) imaging could be applied to quantitatively assess LA function and data so obtained could be used as a potential marker of atrial reverse remodeling after RFCA. Of interest, using delayed-enhancement MRI to quantify and visualize the extent of scar tissue in atrial myocardium, Kuppahally et al.[28] studied 65 patients with paroxysmal AF (44%) or persistent AF (56%), in whom 2-D echocardiography and Doppler-derived LA strain (rate) had been obtained. They demonstrated that fibrosis values correlated inversely with LA mid-lateral strain (r= −0.5, P= 0.003) and strain rate (r= −0.4, P< 0.005). Patients with persistent AF seemed to have more fibrotic scar compared to those with paroxysmal AF (22±17% vs.14±9%, P=0.04) and lower mid-septal (27±14% vs. 38±16%, P= 0.01) and mid-lateral (35±16% vs. 45±14% P= 0.03) LA strains. Furthermore, multivariable regression showed that mid-lateral strain (r= −0.5, P= 0.006) and strain rate (r= −0.4, P= 0.01) inversely corresilated with the extent of fibrosis independent of other echocardiographic parameters. Based on these results, they suggested that 2-D echocardiography conjoined with the Doppler method could provide accurate information to reflect LA structural and functional changes related to AF.

Practical Considerations

Despite RFCA being an effective means for eliminating AF, this approach is limited by potentially serious complications, the rate of which is in the range of 3.5 to 5%.[29,31] Among these are pneumothorax, pericardial effusion/cardiac tamponade, stroke/transient ischemic attack, femoral pseudoaneurysm, valvular damage, arterio-venous fistula, phrenic nerve injury, pulmonary vein thrombosis, atrio-esophageal fistula and death. Less well recognized are silent cerebral microembolism[32,34] and recently described LA diastolic dysfunction.[3] The incidence of silent cerebral microembolism has been reported to be more than 10% (ranging from 4.3 to 37.5 % depending on the RFCA technology used) as documented by cerebral diffusion-weighted MRI.[32-34] On the other hand, it is difficult to determine the exact incidence of diastolic LA dysfunction produced by RFCA of AF as it may coexist with systolic LA dysfunction. Although Gibson et al.[3] reported that the incidence of the “stiff LA syndrome” presumably caused by RFCA-induced scar was only 1.4%, the study was confined to symptomatic patients with “less than mild” mitral regurgitation on echocardiography. Judging from effects of thermal injury to the atrium,[9] and considering complex pathophysiology of AF,[35-39] the exact incidence of RFCA-induced LA diastolic dysfunction is likely to be more prevalent than is generally realized. First, many patients have preexisting atrial scar (fibrosis/low-voltage tissue) caused by aging and AF.[15,35] Experimentally, AF and LA fibrotic scar (electrical and structural remodeling) have been shown to be mutually causative, accounting for “AF begets AF”.[36-39] Clinically, tachycardia-induced atrial cardiomyopathy manifested as atrial stunning is not infrequently seen following conversion to sinus rhythm with surgery, antiarrhythmic drugs, electrical cardiversion and RFCA.[15,25,26,50] Second, LA diastolic dysfunction with pulmonary hypertension has been demonstrated in some of AF patients without prior RFCA.[41] Third, up to 40% of patients require a second RFCA for recurrence of AF and/or development of atrial flutter/atrial tachycardia.[1] Lastly, many of these AF patients have significant co-morbidities (e.g., heart failure, hypertension, stroke, sleep apnea, chronic obstructive pulmonary disease, etc.), all of which, with or without associated LV dysfunction, can result in atrial myocardial degeneration with AF progression and/or LA dilatation with mechanical dysfunction.[1,42,44] Under these circumstances, RFCA-induced scar will certainly further add to the impairment of systolic and/or diastolic function of the LA.

Also noteworthy, creation of linear lesions during RFCA of AF, especially the septal line, may inadvertently isolate the LA appendage thereby delaying its activation.[44,45] Since the LA appendage plays an important role in the LA reservoir function and is the most common site of thrombus formation,[21,46] whether this latter complication by itself, or as part of global LA dysfunction is serious enough to predispose to forming thrombus despite elimination of AF has been raised as an issue of concern.[44,45]

Taken together, while either MSCT or cardiovascular MRI may be needed for guiding the RFCA of AF procedure, we propose that biplane two-dimensional echocardiography along with tissue Doppler imaging and Doppler-derived strain (rate) imaging be systematically obtained before and periodically after RFCA of AF for evaluation of the LA function (both systolic and diastolic) in this subset of patients. Early detection of any new or worsening LA dysfunction function and/or pulmonary hypertension should prompt physicians to appropriately institute a therapeutic regimen of preload and/or afterload reduction for preventing development of heart failure which is also one of independent risks of severe stroke.[47]

Also of clinical relevance, because mechanisms underlying thrombogenesis in AF are complex and only partly understood, the answer to the question as to whether anticoagulation therapy can be discontinued after apparent success of RFCA remains uncertain and debatable.[48,49] In general, warfarin is recommended for all patients for at least 2 months after the RFCA procedure and decisions regarding the use of warfarin thereafter are based on the risk stratification for stroke even after seemingly successful restoration of sinus rhythm. Discontinuation of warfarin therapy is generally not recommended in patients who have a CHADS2 score (congestive heart failure, hypertension, age >75 years, diabetes mellitus, and prior stroke or transient ischemic attack) > 2.50. Herein, we advocate that alteration of the LA function after RFCA of AF be additionally taken into consideration during follow-up evaluation of these patients. Specifically, anticoagulation therapy should be continued in patients with spontaneous echo contrast which is usually found in the LA appendage,[46] and those with low LA ejection fraction, reduced or absent emptying and filling velocities of the LA, especially the LA appendage.[46]

Conclusions

From an electromechanical perspective, 2-D echocardiography along with tissue Doppler (velocity) imaging and Doppler-derived strain (rate) imaging can be noninvasively used to provide a better understanding of the LA function and its relationship with LV function as well as PV circulation. Routine and systematic application of these technologies before and after RFCA of AF will allow early detection of LA dysfunction, both systolic and/or diastolic, in the presence or absence of associated LV dysfunction. It is anticipated that proper initiation of preload and/or afterload reduction therapy can prevent or minimize new or worsening heart failure and pulmonary hypertension and that prudent anticoagulation therapy may reduce the risk of thromboembolism in this subset of patients.

References

  • 1.Cappato Riccardo, Calkins Hugh, Chen Shih-Ann, Davies Wyn, Iesaka Yoshito, Kalman Jonathan, Kim You-Ho, Klein George, Natale Andrea, Packer Douglas, Skanes Allan, Ambrogi Federico, Biganzoli Elia. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010 Feb;3 (1):32–8. doi: 10.1161/CIRCEP.109.859116. [DOI] [PubMed] [Google Scholar]
  • 2.Wilber David J, Pappone Carlo, Neuzil Petr, De Paola Angelo, Marchlinski Frank, Natale Andrea, Macle Laurent, Daoud Emile G, Calkins Hugh, Hall Burr, Reddy Vivek, Augello Giuseppe, Reynolds Matthew R, Vinekar Chandan, Liu Christine Y, Berry Scott M, Berry Donald A. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010 Jan 27;303 (4):333–40. doi: 10.1001/jama.2009.2029. [DOI] [PubMed] [Google Scholar]
  • 3.Gibson Douglas N, Di Biase Luigi, Mohanty Prasant, Patel Jigar D, Bai Rong, Sanchez Javier, Burkhardt J David, Heywood J Thomas, Johnson Allen D, Rubenson David S, Horton Rodney, Gallinghouse G Joseph, Beheiry Salwa, Curtis Guy P, Cohen David N, Lee Mark Y, Smith Michael R, Gopinath Devi, Lewis William R, Natale Andrea. Stiff left atrial syndrome after catheter ablation for atrial fibrillation: clinical characterization, prevalence, and predictors. Heart Rhythm. 2011 Sep;8 (9):1364–71. doi: 10.1016/j.hrthm.2011.02.026. [DOI] [PubMed] [Google Scholar]
  • 4.Mehta S, Charbonneau F, Fitchett D H, Marpole D G, Patton R, Sniderman A D. The clinical consequences of a stiff left atrium. Am. Heart J. 1991 Oct;122 (4 Pt 1):1184–91. doi: 10.1016/0002-8703(91)90498-7. [DOI] [PubMed] [Google Scholar]
  • 5.Tops Laurens F, van der Wall Ernst E, Schalij Martin J, Bax Jeroen J. Multi-modality imaging to assess left atrial size, anatomy and function. Heart. 2007 Nov;93 (11):1461–70. doi: 10.1136/hrt.2007.116467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Zhang Qing, Yip Gabriel Wai-Kwok, Yu Cheuk-Man. Approaching regional left atrial function by tissue Doppler velocity and strain imaging. Europace. 2008 Nov;10 Suppl 3 ():iii62–9. doi: 10.1093/europace/eun237. [DOI] [PubMed] [Google Scholar]
  • 7.Elayi Claude S, Verma Atul, Di Biase Luigi, Ching Chi Keong, Patel Dimpi, Barrett Conor, Martin David, Rong Bai, Fahmy Tamer S, Khaykin Yaariv, Hongo Richard, Hao Steven, Pelargonio Gemma, Dello Russo Antonio, Casella Michela, Santarelli Pietro, Potenza Domenico, Fanelli Raffaele, Massaro Raimondo, Arruda Mauricio, Schweikert Robert A, Natale Andrea. Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategies. Heart Rhythm. 2008 Dec;5 (12):1658–64. doi: 10.1016/j.hrthm.2008.09.016. [DOI] [PubMed] [Google Scholar]
  • 8.Peters Dana C, Wylie John V, Hauser Thomas H, Nezafat Reza, Han Yuchi, Woo Jeong Joo, Taclas Jason, Kissinger Kraig V, Goddu Beth, Josephson Mark E, Manning Warren J. Recurrence of atrial fibrillation correlates with the extent of post-procedural late gadolinium enhancement: a pilot study. JACC Cardiovasc Imaging. 2009 Mar;2 (3):308–16. doi: 10.1016/j.jcmg.2008.10.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Peters Dana C, Wylie John V, Hauser Thomas H, Kissinger Kraig V, Botnar René M, Essebag Vidal, Josephson Mark E, Manning Warren J. Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience. Radiology. 2007 Jun;243 (3):690–5. doi: 10.1148/radiol.2433060417. [DOI] [PubMed] [Google Scholar]
  • 10.Wylie John V, Peters Dana C, Essebag Vidal, Manning Warren J, Josephson Mark E, Hauser Thomas H. Left atrial function and scar after catheter ablation of atrial fibrillation. Heart Rhythm. 2008 May;5 (5):656–62. doi: 10.1016/j.hrthm.2008.02.008. [DOI] [PubMed] [Google Scholar]
  • 11.Jeevanantham Vinodh, Ntim William, Navaneethan Sankar D, Shah Sidharth, Johnson Alex C, Hall Burr, Shah Abrar, Hundley W Gregory, Daubert James P, Fitzgerald David. Meta-analysis of the effect of radiofrequency catheter ablation on left atrial size, volumes and function in patients with atrial fibrillation. Am. J. Cardiol. 2010 May 01;105 (9):1317–26. doi: 10.1016/j.amjcard.2009.12.046. [DOI] [PubMed] [Google Scholar]
  • 12.Pagel Paul S, Kehl Franz, Gare Meir, Hettrick Douglas A, Kersten Judy R, Warltier David C. Mechanical function of the left atrium: new insights based on analysis of pressure-volume relations and Doppler echocardiography. Anesthesiology. 2003 Apr;98 (4):975–94. doi: 10.1097/00000542-200304000-00027. [DOI] [PubMed] [Google Scholar]
  • 13.Prioli A, Marino P, Lanzoni L, Zardini P. Increasing degrees of left ventricular filling impairment modulate left atrial function in humans. Am. J. Cardiol. 1998 Sep 15;82 (6):756–61. doi: 10.1016/s0002-9149(98)00452-4. [DOI] [PubMed] [Google Scholar]
  • 14.Appleton C P, Hatle L K, Popp R L. Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study. J. Am. Coll. Cardiol. 1988 Aug;12 (2):426–40. doi: 10.1016/0735-1097(88)90416-0. [DOI] [PubMed] [Google Scholar]
  • 15.Rosca Monica, Lancellotti Patrizio, Popescu Bogdan A, Piérard Luc A. Left atrial function: pathophysiology, echocardiographic assessment, and clinical applications. Heart. 2011 Dec;97 (23):1982–9. doi: 10.1136/heartjnl-2011-300069. [DOI] [PubMed] [Google Scholar]
  • 16.Abhayaratna Walter P, Seward James B, Appleton Christopher P, Douglas Pamela S, Oh Jae K, Tajik A Jamil, Tsang Teresa S M. Left atrial size: physiologic determinants and clinical applications. J. Am. Coll. Cardiol. 2006 Jun 20;47 (12):2357–63. doi: 10.1016/j.jacc.2006.02.048. [DOI] [PubMed] [Google Scholar]
  • 17.Schneider Carsten, Malisius Rainer, Krause Korff, Lampe Friedrun, Bahlmann Edda, Boczor Sigrid, Antz Matthias, Ernst Sabine, Kuck Karl-Heinz. Strain rate imaging for functional quantification of the left atrium: atrial deformation predicts the maintenance of sinus rhythm after catheter ablation of atrial fibrillation. Eur. Heart J. 2008 Jun;29 (11):1397–409. doi: 10.1093/eurheartj/ehn168. [DOI] [PubMed] [Google Scholar]
  • 18.Liang Hsin-Yueh, Cheng Alan, Chang Kuan-Cheng, Berger Ronald D, Agarwal Kunal, Eulitt Patrick, Corretti Mary, Tomaselli Gordon, Calkins Hugh, Kass David A, Abraham Theodore P. Influence of atrial function and mechanical synchrony on LV hemodynamic status in heart failure patients on resynchronization therapy. JACC Cardiovasc Imaging. 2011 Jul;4 (7):691–8. doi: 10.1016/j.jcmg.2011.02.019. [DOI] [PubMed] [Google Scholar]
  • 19.Rossvoll O, Hatle L K. Pulmonary venous flow velocities recorded by transthoracic Doppler ultrasound: relation to left ventricular diastolic pressures. J. Am. Coll. Cardiol. 1993 Jun;21 (7):1687–96. doi: 10.1016/0735-1097(93)90388-h. [DOI] [PubMed] [Google Scholar]
  • 20.Smiseth O A, Thompson C R, Lohavanichbutr K, Ling H, Abel J G, Miyagishima R T, Lichtenstein S V, Bowering J. The pulmonary venous systolic flow pulse--its origin and relationship to left atrial pressure. J. Am. Coll. Cardiol. 1999 Sep;34 (3):802–9. doi: 10.1016/s0735-1097(99)00300-9. [DOI] [PubMed] [Google Scholar]
  • 21.Al-Saady N M, Obel O A, Camm A J. Left atrial appendage: structure, function, and role in thromboembolism. Heart. 1999 Nov;82 (5):547–54. doi: 10.1136/hrt.82.5.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Piotrowski G, Goch A, Wlazłowski R, Gawor Z, Goch J H. Non-invasive methods of atrial function evaluation in heart diseases. Med. Sci. Monit. 2001 Feb 24;6 (4):827–39. [PubMed] [Google Scholar]
  • 23.Di Salvo Giovanni, Caso Pio, Lo Piccolo Rosalia, Fusco Angela, Martiniello Alfonso R, Russo Maria G, D'Onofrio Antonio, Severino Sergio, Calabró Paolo, Pacileo Giuseppe, Mininni Nicola, Calabró Raffaele. Atrial myocardial deformation properties predict maintenance of sinus rhythm after external cardioversion of recent-onset lone atrial fibrillation: a color Doppler myocardial imaging and transthoracic and transesophageal echocardiographic study. Circulation. 2005 Jul 19;112 (3):387–95. doi: 10.1161/CIRCULATIONAHA.104.463125. [DOI] [PubMed] [Google Scholar]
  • 24.Wang Tian, Wang Mei, Fung Jeffrey W H, Yip Gabriel W K, Zhang Yan, Ho Pearl P Y, Tse Deco M K, Yu Cheuk Man, Sanderson John E. Atrial strain rate echocardiography can predict success or failure of cardioversion for atrial fibrillation: a combined transthoracic tissue Doppler and transoesophageal imaging study. Int. J. Cardiol. 2007 Jan 08;114 (2):202–9. doi: 10.1016/j.ijcard.2006.01.051. [DOI] [PubMed] [Google Scholar]
  • 25.Thomas L, McKay T, Byth K, Marwick T H. Abnormalities of left atrial function after cardioversion: an atrial strain rate study. Heart. 2007 Jan;93 (1):89–95. doi: 10.1136/hrt.2006.088609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Escudero E M, San Mauro M, Lauglé C. Bilateral atrial function after chemical cardioversion of atrial fibrillation with amiodarone: an echo-Doppler study. J Am Soc Echocardiogr. 1998 Apr;11 (4):365–71. doi: 10.1016/s0894-7317(98)70104-x. [DOI] [PubMed] [Google Scholar]
  • 27.Kaya Ergün Baris, Tokgözoglu Lale, Aytemir Kudret, Kocabas Ugur, Tülümen Erol, Deveci Onur Sinan, Köse Sedat, Kabakçi Giray, Nazli Nasih, Ozkutlu Hilmi, Oto Ali. Atrial myocardial deformation properties are temporarily reduced after cardioversion for atrial fibrillation and correlate well with left atrial appendage function. Eur J Echocardiogr. 2008 Jul;9 (4):472–7. doi: 10.1016/j.euje.2007.07.003. [DOI] [PubMed] [Google Scholar]
  • 28.Kuppahally Suman S, Akoum Nazem, Burgon Nathan S, Badger Troy J, Kholmovski Eugene G, Vijayakumar Sathya, Rao Swati N, Blauer Joshua, Fish Eric N, Dibella Edward V R, Macleod Rob S, McGann Christopher, Litwin Sheldon E, Marrouche Nassir F. Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: relationship to left atrial structural remodeling detected by delayed-enhancement MRI. Circ Cardiovasc Imaging. 2010 May;3 (3):231–9. doi: 10.1161/CIRCIMAGING.109.865683. [DOI] [PubMed] [Google Scholar]
  • 29.Sung Ruey J, Lauer Michael R. Atrial fibrillation: can we cure it if we can't explain it? J. Cardiovasc. Electrophysiol. 2005 May;16 (5):505–7. doi: 10.1111/j.1540-8167.2005.50021.x. [DOI] [PubMed] [Google Scholar]
  • 30.Sung Ruey J, Lauer Michael R. Is electrode catheter ablation-induced phrenic nerve injury really a benign condition? J. Cardiovasc. Electrophysiol. 2006 Sep;17 (9):949–50. doi: 10.1111/j.1540-8167.2006.00574.x. [DOI] [PubMed] [Google Scholar]
  • 31.Baman Timir S, Jongnarangsin Krit, Chugh Aman, Suwanagool Arisara, Guiot Aurelie, Madenci Arin, Walsh Spencer, Ilg Karl J, Gupta Sanjaya K, Latchamsetty Rakesh, Bagwe Suveer, Myles James D, Crawford Thomas, Good Eric, Bogun Frank, Pelosi Frank, Morady Fred, Oral Hakan. Prevalence and predictors of complications of radiofrequency catheter ablation for atrial fibrillation. J. Cardiovasc. Electrophysiol. 2011 Jun;22 (6):626–31. doi: 10.1111/j.1540-8167.2010.01995.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Schwarz Niko, Kuniss Malte, Nedelmann Max, Kaps Manfred, Bachmann Georg, Neumann Thomas, Pitschner Heinz-Friedrich, Gerriets Tibo. Neuropsychological decline after catheter ablation of atrial fibrillation. Heart Rhythm. 2010 Dec;7 (12):1761–7. doi: 10.1016/j.hrthm.2010.07.035. [DOI] [PubMed] [Google Scholar]
  • 33.Gaita Fiorenzo, Caponi Domenico, Pianelli Martina, Scaglione Marco, Toso Elisabetta, Cesarani Federico, Boffano Carlo, Gandini Giovanni, Valentini Maria Consuelo, De Ponti Roberto, Halimi Franck, Leclercq Jean François. Radiofrequency catheter ablation of atrial fibrillation: a cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation. Circulation. 2010 Oct 26;122 (17):1667–73. doi: 10.1161/CIRCULATIONAHA.110.937953. [DOI] [PubMed] [Google Scholar]
  • 34.Herrera Siklódy Claudia, Deneke Thomas, Hocini Mélèze, Lehrmann Heiko, Shin Dong-In, Miyazaki Shinsuke, Henschke Susanne, Fluegel Peter, Schiebeling-Römer Jochen, Bansmann Paul M, Bourdias Thomas, Dousset Vincent, Haïssaguerre Michel, Arentz Thomas. Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation ablation technologies in a multicenter study. J. Am. Coll. Cardiol. 2011 Aug 09;58 (7):681–8. doi: 10.1016/j.jacc.2011.04.010. [DOI] [PubMed] [Google Scholar]
  • 35.Verma Atul, Wazni Oussama M, Marrouche Nassir F, Martin David O, Kilicaslan Fethi, Minor Stephen, Schweikert Robert A, Saliba Walid, Cummings Jennifer, Burkhardt J David, Bhargava Mandeep, Belden William A, Abdul-Karim Ahmad, Natale Andrea. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. J. Am. Coll. Cardiol. 2005 Jan 18;45 (2):285–92. doi: 10.1016/j.jacc.2004.10.035. [DOI] [PubMed] [Google Scholar]
  • 36.Morillo C A, Klein G J, Jones D L, Guiraudon C M. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation. 1995 Mar 01;91 (5):1588–95. doi: 10.1161/01.cir.91.5.1588. [DOI] [PubMed] [Google Scholar]
  • 37.Wijffels M C, Kirchhof C J, Dorland R, Allessie M A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995 Oct 01;92 (7):1954–68. doi: 10.1161/01.cir.92.7.1954. [DOI] [PubMed] [Google Scholar]
  • 38.Hoit B D, Shao Y, Gabel M. Left atrial systolic and diastolic function accompanying chronic rapid pacing-induced atrial failure. Am. J. Physiol. 1998 Jul;275 (1 Pt 2):H183–9. doi: 10.1152/ajpheart.1998.275.1.H183. [DOI] [PubMed] [Google Scholar]
  • 39.Eckstein Jens, Verheule Sander, de Groot Natasja M, de Groot Natasja, Allessie Maurits, Schotten Ulrich. Mechanisms of perpetuation of atrial fibrillation in chronically dilated atria. Prog. Biophys. Mol. Biol. 2008 Apr 2;97 (2-3):435–51. doi: 10.1016/j.pbiomolbio.2008.02.019. [DOI] [PubMed] [Google Scholar]
  • 40.Sparks P B, Jayaprakash S, Vohra J K, Mond H G, Yapanis A G, Grigg L E, Kalman J M. Left atrial "stunning" following radiofrequency catheter ablation of chronic atrial flutter. J. Am. Coll. Cardiol. 1998 Aug;32 (2):468–75. doi: 10.1016/s0735-1097(98)00253-8. [DOI] [PubMed] [Google Scholar]
  • 41.Kahn TA, Heywood JT, Johnson AD, Smith MR, Rubenson D. Left atrial diastolic dysfunction and pulmonary venous hypertension: hemodynamic and echocardiographic characteristics. J Cardiac Failurr. 2009;0:0–0. doi: 10.4022/jafib.1117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.de Vos Cees B, Pisters Ron, Nieuwlaat Robby, Prins Martin H, Tieleman Robert G, Coelen Robert-Jan S, van den Heijkant Antonius C, Allessie Maurits A, Crijns Harry J G M. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J. Am. Coll. Cardiol. 2010 Feb 23;55 (8):725–31. doi: 10.1016/j.jacc.2009.11.040. [DOI] [PubMed] [Google Scholar]
  • 43.Ng Chee Yuan, Liu Tong, Shehata Michael, Stevens Steven, Chugh Sumeet S, Wang Xunzhang. Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am. J. Cardiol. 2011 Jul 01;108 (1):47–51. doi: 10.1016/j.amjcard.2011.02.343. [DOI] [PubMed] [Google Scholar]
  • 44.Chan Chin Pang, Wong Wai Shun, Pumprueg Satchana, Veerareddy Srikar, Billakanty Sreedhar, Ellis Christopher, Chae Sanders, Buerkel Daniel, Aasbo Johan, Crawford Thomas, Good Eric, Jongnarangsin Krit, Ebinger Matthew, Bogun Frank, Pelosi Frank, Oral Hakan, Morady Fred, Chugh Aman. Inadvertent electrical isolation of the left atrial appendage during catheter ablation of persistent atrial fibrillation. Heart Rhythm. 2010;7 (2):173–80. doi: 10.1016/j.hrthm.2009.10.036. [DOI] [PubMed] [Google Scholar]
  • 45.Jiang Chen-Xi, Sang Cai-Hua, Dong Jian-Zeng, Liu Xing-Peng, Long De-Yong, Yu Rong-Hui, Tang Ri-Bo, Wu Jia-Hui, Ning Man, Liu Chang, Ma Chang-Sheng. Significant left atrial appendage activation delay complicating aggressive septal ablation during catheter ablation of persistent atrial fibrillation. Pacing Clin Electrophysiol. 2010 Jun 01;33 (6):652–60. doi: 10.1111/j.1540-8159.2010.02753.x. [DOI] [PubMed] [Google Scholar]
  • 46.Al-Saady N M, Obel O A, Camm A J. Left atrial appendage: structure, function, and role in thromboembolism. Heart. 1999 Nov;82 (5):547–54. doi: 10.1136/hrt.82.5.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Appelros Peter, Nydevik Ingegerd, Seiger Ake, Terént Andreas. Predictors of severe stroke: influence of preexisting dementia and cardiac disorders. Stroke. 2002 Oct;33 (10):2357–62. doi: 10.1161/01.str.0000030318.99727.fa. [DOI] [PubMed] [Google Scholar]
  • 48.Cakulev Ivan, Waldo Albert L. Do not stop the warfarin until ... J. Am. Coll. Cardiol. 2010 Feb 23;55 (8):744–6. doi: 10.1016/j.jacc.2009.12.008. [DOI] [PubMed] [Google Scholar]
  • 49.Eitel Charlotte, Hindricks Gerhard. Does catheter ablation eliminate the need for oral anticoagulation? Circ Arrhythm Electrophysiol. 2011 Oct;4 (5):595–7. doi: 10.1161/CIRCEP.111.966218. [DOI] [PubMed] [Google Scholar]
  • 50.Calkins Hugh, Brugada Josep, Packer Douglas L, Cappato Riccardo, Chen Shih-Ann, Crijns Harry J G, Damiano Ralph J, Davies D Wyn, Haines David E, Haissaguerre Michel, Iesaka Yoshito, Jackman Warren, Jais Pierre, Kottkamp Hans, Kuck Karl Heinz, Lindsay Bruce D, Marchlinski Francis E, McCarthy Patrick M, Mont J Lluis, Morady Fred, Nademanee Koonlawee, Natale Andrea, Pappone Carlo, Prystowsky Eric, Raviele Antonio, Ruskin Jeremy N, Shemin Richard J. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace. 2007 Jun;9 (6):335–79. doi: 10.1093/europace/eum120. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Atrial Fibrillation are provided here courtesy of CardioFront, LLC

RESOURCES